WEI LIN
Login to view DISC.Wei Lin serves as the Chief Medical Officer at Revolution Medicines, bringing extensive experience in oncology and drug development. An MD from Harvard Medical School, he has held senior leadership positions at Erasca, Nektar Therapeutics, and Genentech, focusing on clinical strategy and portfolio management.
He is passionate about making a broad impact on patients lives, which motivated his transition from academic medicine to the biopharma industry. He values teamwork and a collaborative culture, inspired by what he describes as the "elegance of biology" in finding new cancer treatments.
Unique fact: Dr. Lin is leading the charge in developing therapies for RAS-addicted cancers, a notoriously difficult-to-treat set of malignancies.
Read the full overview →How WEI shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics WEI cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Other REVOLUTION Medicines Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.